EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Sunshine Biopharma, Inc. (SBFM) had EBIT Margin of -20.87% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$8.58M |
|
$-2.14M |
|
$5.55M |
|
$3.03M |
|
$10.37M |
|
$-1.79M |
|
$0.06M |
|
$-1.73M |
|
$-1.72M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
$-2.13M |
|
$-1.79M |
|
$-1.56M |
|
4.16M |
|
4.16M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$26.85M |
|
$0.56M |
|
$3.23M |
|
$30.08M |
|
$6.44M |
|
-- |
|
$0.60M |
|
$7.04M |
|
$23.03M |
|
$21.15M |
|
$23.04M |
|
4.91M |
|
| Cash Flow Statement Financials | |
$-5.33M |
|
$-0.84M |
|
$4.75M |
|
$9.69M |
|
$9.12M |
|
$-0.56M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
35.31% |
|
-20.87% |
|
|
EBIT Margin |
-20.87% |
-- |
|
-20.20% |
|
-24.96% |
|
$-5.51M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.41 |
|
2.48 |
|
36.30 |
|
-9.30% |
|
-10.12% |
|
-7.12% |
|
-9.29% |
|
$4.70 |
|
$-1.32 |
|
$-1.28 |
|